Denis Kirilov Razsolkov

Does randomization matter in rare disease clinical trials

Background Conducting Rare Disease Clinical Trials poses a wide variety of research challenges. Many techniques that are usually considered the best standard for evaluating new therapies are more difficult to implement here. This also holds in terms of randomization in clinical trials. The question arises how to random...